10. Shareholders' Deficit We repurchased $500 million and $375 million of our common shares, in the aggregate, through share repurchase programs during the three months ended September 30, 2026 and 2025, respectively. We funded the repurchases with available cash. The common shares repurchased are held in treasury to be used for general corporate purposes. The following table presents the accelerated share repurchase programs executed during the three months ended September 30, 2026 and 2025: | | | | | | | | | | | | | | | | | | | | | | Quarter Entered | Date Concluded | Aggregate Purchase Price
(in millions) | Initial Shares
(in millions) | Reference Price | Final Shares
(in millions) | Weighted Average Price per Common Share | | Q1 FY27 | 9/18/2026 | $500 | 1.7 | $234.16 | 0.5 | $231.63 | | Q1 FY26 | 10/31/2025 | $375 | 2.0 | $148.12 | 0.4 | $151.88 |
Accumulated Other Comprehensive Loss The following tables summarize the changes in the balance of accumulated other comprehensive loss by component and in total: | | | | | | | | | | | | | | | | | | | (in millions) | Foreign
Currency
Translation
Adjustments | | Unrealized
Gain/(Loss) on
Derivatives,
net of tax | | Accumulated Other
Comprehensive
Loss | | Balance at June 30, 2026 | $ | (140) | | | $ | (25) | | | $ | (165) | | | Other comprehensive income, before reclassifications | 4 | | | 4 | | | 8 | | | Amounts reclassified to earnings | — | | | (2) | | | (2) | | Total other comprehensive income attributable to Cardinal Health, Inc., net of tax benefit of $7 million | 4 | | | 2 | | | 6 | | | Balance at September 30, 2026 | $ | (136) | | | $ | (23) | | | $ | (159) | |
| | | | | | | | | | | | | | | | | | | (in millions) | Foreign
Currency
Translation
Adjustments | | Unrealized
Gain/(Loss) on
Derivatives,
net of tax | | Accumulated Other
Comprehensive
Loss | | Balance at June 30, 2025 | $ | (141) | | | $ | (14) | | | $ | (155) | | | Other comprehensive (loss)/income, before reclassifications | (4) | | | 2 | | | (2) | | | Amounts reclassified to earnings | — | | | (2) | | | (2) | | Total other comprehensive loss attributable to Cardinal Health, Inc., net of tax expense of $1 million | (4) | | | — | | | (4) | | | Balance at September 30, 2025 | $ | (145) | | | $ | (14) | | | $ | (159) | |
|